Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 360, Suchdauer: 3.4s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

von Elshorbagy A. ; Lyons A. R. M. ; Vallejo-Vaz A. J. ; et al.
- View full text via BASE
Merkliste

2
Hyperlipoproteinemia(a) in coronary artery disease patients: who are patients with very high levels and how do they respond to the PCSK9 antibody therapy?

von Novakovic, M ; Trsan, J ; Krevel, B ; et al.

European Heart Journal ; volume 44, issue Supplement_2 ; ISSN 0195-668X 1522-9645
- View full text via BASE
Merkliste

3
Conformation of Polymer Brushes at Aqueous Surfaces Determined with X-ray and Neutron Reflectometry. 2. High-Density Phase Transition of Lipopolyoxazolines

von Wurlitzer, A. ; Politsch, E. ; Huebner, S. ; et al.

Macromolecules. 34(5):1334-1342
- View full text at ACS Publications
Merkliste

4
Conformation of Polymer Brushes at Aqueous Surfaces Determined with X-ray and Neutron Reflectometry. 1. Novel Data Evaluation Procedure for Polymers at Interfaces

von Politsch, E. ; Cevc, G. ; Wurlitzer, A. ; et al.

Macromolecules. 34(5):1328-1333
- View full text at ACS Publications
Merkliste

5
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

von Vallejo-Vaz, AJ ; Stevens, CAT ; Lyons, ARM ; et al.

1725 ; 1713

Schlagworte: Science & Technology; Life Sciences & Biomedicine; Medicine; General & Internal; General & Internal Medicine; PREVALENCE; CLINICIAN; GUIDANCE; INSIGHTS; EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC); 11 Medical and Health Sciences
- View full text via BASE
Merkliste

6
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

von White, HD ; Steg, PG ; Szarek, M ; et al.

Schlagworte: Alirocumab; Prevention; MI types; Mortality
- View full text via BASE
Merkliste

7
Effect of alirocumab on mortality after acute coronary syndromes. An analysis of the ODYSSEY OUTCOMES randomized clinical trial

von Steg, PG ; Szarek, M ; Bhatt, DL ; et al.

112 ; 103

Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Peripheral Vascular Disease; Cardiovascular System & Cardiology; acute coronary syndrome; alirocumab; cholesterol; mortality; PCSK9 protein; MONOCLONAL-ANTIBODY; REDUCING LIPIDS; EFFICACY; SAFETY; EVOLOCUMAB; PCSK9; Aged; Antibodies; Monoclonal; Humanized; LDL; Double-Blind Method; Drug Therapy; Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Injections
- View full text via BASE
Merkliste

8
Risk categorization using New American College of Cardiology/American Heart Association guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes

von Roe, MT ; Li, QH ; Bhatt, DL ; et al.

1589 ; 1578

Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Peripheral Vascular Disease; Cardiovascular System & Cardiology; alirocumab; acute coronary syndrome; dyslipidemias; guideline; CARDIOVASCULAR OUTCOMES; STATIN THERAPY; ADDING EZETIMIBE; BENEFIT; EVENTS; PCSK9; Cardiovascular System & Hematology; 1102 Cardiorespiratory Medicine and Haematology; 1103 Clinical Sciences; 1117 Public Health and Health Services
- View full text via BASE
Merkliste

9
Genetic and clinical characteristics of heterozygous and homozygous LPL deficiency: Case series

von Marusic, T.M. ; Bizjan, B. Jenko ; Šuštar, U. ; et al.

In Atherosclerosis August 2022 355
- View full text via DOI
Merkliste

10
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

von Schwartz, Gregory G. ; Gabriel Steg, P.h. ; Bhatt, Deepak L. ; et al.

In Journal of the American College of Cardiology 3 August 2021 78(5):421-433
- View full text via DOI
Merkliste

11
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

von Schwartz, Gregory G. ; Steg, Ph. Gabriel ; Bhatt, Deepak L. ; et al.

In The Lancet Diabetes & Endocrinology August 2019 7(8):618-628
- View full text via DOI
Merkliste

12
The effect of membrane softeners on rigidity of lipid vesicle bilayers: Derivation from vesicle size changes

von Elsayed, Mustafa M.A. ; Ibrahim, Marwa M. ; Cevc, Gregor

In Chemistry and Physics of Lipids January 2018 210:98-108
- View full text via DOI
Merkliste

13
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

von Schwartz, G ; Szarek, M ; Bittner, V ; et al.

Schlagworte: acute coronary syndrome; lipoprotein(a); low-density lipoprotein cholesterol; PCSK9 inhibitor; info:eu-repo/semantics/article
- Zum Volltext über OAIster
Merkliste

14
Terahertz Emission from Tubular Pb(Zr,Ti)O3 Nanostructures

von Scott, J. F. ; Fan, H. J. ; Kawasaki, S. ; et al.

Nano Letters. 8(12):4404-4409
- View full text at ACS Publications
Merkliste

15
93Nb NMR and Fe 3+ EPR study of local magnetic properties of magnetoelectric Pb(Fe 1/2Nb 1/2)O 3

von Laguta, V.V. ; Rosa, J. ; Jastrabik, L. ; et al.

In Materials Research Bulletin 2010 45(11):1720-1727
- View full text via DOI
Merkliste

16
The use of solvent relaxation technique to investigate headgroup hydration and protein binding of simple and mixed phosphatidylcholine/surfactant bilayer membranes

von Rieber, K. ; Sýkora, J. ; Olżyńska, A. ; et al.

In BBA - Biomembranes 2007 1768(5):1050-1058
- View full text via DOI
Merkliste

17
Comparison of CW-EPR and ESEEM technique for determination of water permeability profile in liposome membranes

von Noethig-Laslo, V. ; Cevc, P. ; Arčon, D. ; et al.

Applied Magnetic Resonance. March 2004 27(1-2):303-309
- Zum Volltext (via ReDI)
Merkliste

18
Hydrophobic Barrier in Liposomes Studied by FT-ESEEM

von Noethig-Laslo, V. ; Cevc, P. ; Arcon, D. ; et al.

Origins of life and evolution of the biosphere. February 2004 34(1-2):237-242
- Zum Volltext (via ReDI)
Merkliste

19
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

von Ray, K ; Colhoun, H ; Szarek, M ; et al.

Schlagworte: Aged; Antibodies, Monoclonal, Humanized; Cardiovascular Disease; Diabetes Complication; Female; Human; Male; Middle Aged; info:eu-repo/semantics/article
- Zum Volltext über OAIster
Merkliste

20
Weak ferromagnetism of LiMnPO 4

von Arčon, D. ; Zorko, A. ; Cevc, P. ; et al.

In Journal of Physics and Chemistry of Solids 2004 65(11):1773-1777
- View full text via DOI
Merkliste

21
Alirocumab and cardiovascular outcomes after acute coronary syndrome

von Schwartz G. G. ; Steg P. G. ; Szarek M. ; et al.

Schlagworte: Alirocumab; ACS
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

22
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

von Goodman, Shaun G. ; Aylward, Philip E. ; Szarek, Michael ; et al.

Schlagworte: alirocumab; cholesterol; coronary artery bypass graft; lipids; PCSK9; 03 Good Health and Well-being; 03 Salud y bienestar
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

23
The permeability of human cementum in vitro measured by electron paramagnetic resonance

von Petelin, M ; Skalerič, U ; Cevc, P ; et al.

In Archives of Oral Biology 1999 44(3):259-267
- View full text via DOI
Merkliste

24
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

von Bittner, Vera A. ; Szarek, Michael ; Aylward, Philip E. ; et al.

Schlagworte: acute coronary syndromes; alirocumab; low-density lipoprotein cholesterol; major adverse cardiovascular events; proprotein convertase subtilisin/kexin type 9 inhibition; 03 Good Health and Well-being; 03 Salud y bienestar
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

25
Postersitzung 7: Urologische Tumoren — Grundlagenforschung

von Miersch, W.-D. ; Rübben, H. ; Deutz, F. J. ; et al.

Tagung 14.–17. Oktober 1987, Stuttgart. 39:329-358
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag